Walleye Capital’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-99,416
| Closed | -$2.54M | – | 2238 |
|
|
2024
Q3 | $2.54M | Buy |
+99,416
| New | +$2.54M | 0.01% | 660 |
|
|
2024
Q2 | – | Sell |
-56,763
| Closed | -$998K | – | 2735 |
|
|
2024
Q1 | $998K | Buy |
+56,763
| New | +$998K | ﹤0.01% | 1049 |
|
|
2022
Q1 | – | Sell |
-19,295
| Closed | -$174K | – | 2294 |
|
|
2021
Q4 | $174K | Sell |
19,295
-22,619
| -54% | -$204K | 0.01% | 1476 |
|
|
2021
Q3 | $684 | Buy |
+41,914
| New | +$684 | 0.02% | 625 |
|
|
2021
Q2 | – | Sell |
-8,426
| Closed | -$284 | – | 1365 |
|
|
2021
Q1 | $284 | Buy |
+8,426
| New | +$284 | 0.02% | 793 |
|